FCPA Docket: Bio-Rad’s GC whistleblower saga goes on
In today’s news round-up, a California pharmaceutical company is taking an unfair dismissal case to an appeals court, and the lower legislative body of Congress votes to reform the SEC’s whistleblower awards programme.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10